These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Mycophenolate mofetil (MMF) as the first choice immunosuppressive drug in treatment of steroid-dependent nephrotic syndrome in children]. Ogarek I, Szczęsny-Choruz E, Wierzchowska-Słowiaczek E, Kwinta-Rybicka J, Stec Z, Moczulska A, Wilkosz K, Drożdż D. Pol Merkur Lekarski; 2018 Apr 23; 44(262):192-195. PubMed ID: 29775447 [Abstract] [Full Text] [Related]
33. Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab. Vivarelli M, Colucci M, Bonanni A, Verzani M, Serafinelli J, Emma F, Ghiggeri G. Pediatr Nephrol; 2017 Jan 23; 32(1):181-184. PubMed ID: 27687621 [Abstract] [Full Text] [Related]
35. Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome. Gellermann J, Weber L, Pape L, Tönshoff B, Hoyer P, Querfeld U, Gesellschaft für Pädiatrische Nephrologie (GPN). J Am Soc Nephrol; 2013 Oct 23; 24(10):1689-97. PubMed ID: 23813218 [Abstract] [Full Text] [Related]
36. Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome. Kemper MJ, Kuwertz-Broeking E, Bulla M, Mueller-Wiefel DE, Neuhaus TJ. Nephrol Dial Transplant; 2004 May 23; 19(5):1136-41. PubMed ID: 14993510 [Abstract] [Full Text] [Related]